{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T14:09:18Z","timestamp":1695996558397},"reference-count":31,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.8266","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T12:04:09Z","timestamp":1575288249000},"source":"Crossref","is-referenced-by-count":4,"title":["Effects of etanercept and infliximab on bone metabolism indexes in patients with ankylosing spondylitis"],"prefix":"10.3892","author":[{"given":"Chenghai","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, The Affiliated Hospital of Hebei University of Engineering, Handan, Hebei 056000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, The First Central Hospital of Baoding, Baoding, Hebei 071000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"key":"key20200713005408_b1-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"Braun","year":"2007","journal-title":"Lancet"},{"key":"key20200713005408_b2-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s100670050027","article-title":"Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study","volume":"19","author":"Biasi","year":"2000","journal-title":"Clin Rheumatol"},{"key":"key20200713005408_b3-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.autrev.2016.06.001","article-title":"Detection of novel diagnostic antibodies in ankylosing spondylitis: An overview","volume":"15","author":"Quaden","year":"2016","journal-title":"Autoimmun Rev"},{"key":"key20200713005408_b4-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1136\/annrheumdis-2014-205253","article-title":"The epidemiology of extra-articular manifestations in ankylosing spondylitis: A population-based matched cohort study","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"key20200713005408_b5-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/BOR.0b013e3283620777","article-title":"Osteoporosis and vertebral fracture in ankylosing spondylitis","volume":"25","author":"Davey-Ranasinghe","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"key20200713005408_b6-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s10067-012-2018-0","article-title":"High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: A systematic review","volume":"31","author":"van der Weijden","year":"2012","journal-title":"Clin Rheumatol"},{"key":"key20200713005408_b7-etm-0-0-8266","first-page":"2832","article-title":"Study of bone mineral density in patients with ankylosing spondylitis","volume":"7","author":"Singh","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"key20200713005408_b8-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11882-014-0489-6","article-title":"Update on ankylosing spondylitis: Current concepts in pathogenesis","volume":"15","author":"Smith","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"key20200713005408_b9-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1590\/S1518-8787.2016050006265","article-title":"Treatment persistence in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"50","author":"Machado","year":"2016","journal-title":"Rev Saude Publica"},{"key":"key20200713005408_b10-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.semarthrit.2004.08.005","article-title":"Understanding the role of tumor necrosis factor inhibiton in ankylosing spondylitis","volume":"34","author":"Davis","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"key20200713005408_b11-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/1756-185x.12018","article-title":"Working life and physical activity in ankylosing spondylit is pre and post antitumor necrosis factor-alpha therapy","volume":"17","author":"Prince","year":"2014","journal-title":"Int J Rheum Dis"},{"key":"key20200713005408_b12-etm-0-0-8266","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005468.pub2","article-title":"TNF-alpha inhibitors for ankylosing spondylitis","author":"Maxwell","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key20200713005408_b13-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1517\/14740338.7.4.401","article-title":"The safety of celecoxib in ankylosing spondylitis treatment","volume":"7","author":"Poddubnyy","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"key20200713005408_b14-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bone.2015.02.024","article-title":"Loss of bone strength in HLA-B27 transgenic rats is characterized by a high bone turnover and is mainly osteoclast-driven","volume":"75","author":"Rauner","year":"2015","journal-title":"Bone"},{"key":"key20200713005408_b15-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jbspin.2009.12.005","article-title":"New tools for diagnosing spondyloarthropathy","volume":"77","author":"Rostom","year":"2010","journal-title":"Joint Bone Spine"},{"key":"key20200713005408_b16-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1359\/JBMR.0301244","article-title":"Biochemical markers of bone metabolism and prediction of fracture in elderly women","volume":"19","author":"Gerdhem","year":"2004","journal-title":"J Bone Miner Res"},{"key":"key20200713005408_b17-etm-0-0-8266","first-page":"50","article-title":"Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women","volume":"4","author":"Garnero","year":"2004","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"key20200713005408_b18-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1359\/jbmr.2003.18.5.859","article-title":"The type I collagen fragments ICTP and CTX reveal distinct enzymatlc pathways of bone collagen degradation","volume":"18","author":"Garnero","year":"2003","journal-title":"J Bone Miner Res"},{"key":"key20200713005408_b19-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"key20200713005408_b20-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3724\/SP.J.1008.2015.00909","article-title":"Comparison of ASDAS, RAPID3 and BASDAI in assessing disease activity of patients with ankylosing spondylitis","volume":"36","author":"Song","year":"2015","journal-title":"Acad J Second Mil Med Univ"},{"key":"key20200713005408_b21-etm-0-0-8266","first-page":"2286","article-title":"A new approach to defining disease status in AS: The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"key20200713005408_b22-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13561-014-0032-4","article-title":"Biologic TNF inhibiting agents for treatment of rheumatoid arthritis persistence and dosing patterns in Germany","volume":"4","author":"Neubauer","year":"2014","journal-title":"Health Econ Rev"},{"key":"key20200713005408_b23-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1185\/030079905X53261","article-title":"Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial","volume":"21","author":"Fleischmann","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"key20200713005408_b24-etm-0-0-8266","first-page":"1846","article-title":"Efficacy of etanercept in patients with ankylosing spondylitis: A double-blind, randomized, placebo controlled trial","volume":"18","author":"Zhang","year":"2009","journal-title":"Zhongguo Xin Yao Za Zhi"},{"key":"key20200713005408_b25-etm-0-0-8266","first-page":"1424","article-title":"Clinical characteristics of bone disease in multiple myeloma and clinical significance of monitoring bone metabolic markers","volume":"96","author":"Chu","year":"2016","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"key20200713005408_b26-etm-0-0-8266","first-page":"447","article-title":"Significance of dynamic monitoring of bone metabolites in patients with ankylosing spondylitis","volume":"4","author":"Fang","year":"2014","journal-title":"Zhong Guo Yi Yuan Xie Hui"},{"key":"key20200713005408_b27-etm-0-0-8266","first-page":"516","article-title":"Bone mineral density, calcaneal ultrasound, and bone turnover markers in women with ankylosing spondylitis","volume":"29","author":"Speden","year":"2002","journal-title":"J Rheumatol"},{"key":"key20200713005408_b28-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.3892\/etm.2014.1974","article-title":"Etanercept in the treatment of ankylosing spondylitis: A systematic review and meta-analysis","volume":"8","author":"Liu","year":"2014","journal-title":"Exp Ther Med"},{"key":"key20200713005408_b29-etm-0-0-8266","first-page":"88","article-title":"Dermatitis herpetiformis in a patient receiving infliximab for ankylosing spondylitis","volume":"18","author":"Marakli","year":"2008","journal-title":"Eur J Dermatol"},{"key":"key20200713005408_b30-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta11280","article-title":"Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation","volume":"11","author":"McLeod","year":"2007","journal-title":"Health Technol Assess"},{"key":"key20200713005408_b31-etm-0-0-8266","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2478\/v10039-011-0049-4","article-title":"Bone tissue metabolism in men with ankylosing spondylitis","volume":"56","author":"Korczowska","year":"2011","journal-title":"Adv Med Sci"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T23:54:15Z","timestamp":1594598055000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.8266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,2]]},"references-count":31,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.8266","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,2]]}}}